Both have demonstrated that women with detectable CTCs have higher risk of recurrence in the following years; this association was highly significant in patients with hormone receptor (HR)-positive cancer.
1
—
—
Both have demonstrated that women with detectable CTCs have higher risk of recurrence in the following years; this association was highly significant in patients with hormone receptor (HR)-positive cancer.